Bank of New York Mellon’s SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$388K Buy
4,679
+599
+15% +$49.7K ﹤0.01% 3634
2025
Q1
$331K Sell
4,080
-359
-8% -$29.1K ﹤0.01% 3643
2024
Q4
$400K Sell
4,439
-1,176
-21% -$106K ﹤0.01% 3614
2024
Q3
$555K Buy
5,615
+25
+0.4% +$2.47K ﹤0.01% 3450
2024
Q2
$518K Buy
5,590
+744
+15% +$69K ﹤0.01% 3561
2024
Q1
$460K Sell
4,846
-55
-1% -$5.22K ﹤0.01% 3566
2023
Q4
$438K Sell
4,901
-277
-5% -$24.7K ﹤0.01% 3622
2023
Q3
$378K Sell
5,178
-447
-8% -$32.6K ﹤0.01% 3687
2023
Q2
$468K Sell
5,625
-11,269
-67% -$938K ﹤0.01% 3630
2023
Q1
$1.29M Buy
16,894
+100
+0.6% +$7.62K ﹤0.01% 3028
2022
Q4
$1.39M Buy
16,794
+11,099
+195% +$921K ﹤0.01% 3034
2022
Q3
$452K Buy
5,695
+1,181
+26% +$93.7K ﹤0.01% 3614
2022
Q2
$336K Sell
4,514
-93
-2% -$6.92K ﹤0.01% 3822
2022
Q1
$414K Sell
4,607
-2,632
-36% -$237K ﹤0.01% 3822
2021
Q4
$811K Sell
7,239
-4,189
-37% -$469K ﹤0.01% 3504
2021
Q3
$1.44M Buy
11,428
+747
+7% +$93.9K ﹤0.01% 3192
2021
Q2
$1.45M Sell
10,681
-40
-0.4% -$5.42K ﹤0.01% 3200
2021
Q1
$1.45M Buy
10,721
+1,047
+11% +$142K ﹤0.01% 3107
2020
Q4
$1.36M Buy
9,674
+853
+10% +$120K ﹤0.01% 3065
2020
Q3
$983K Buy
8,821
+7
+0.1% +$780 ﹤0.01% 3134
2020
Q2
$987K Sell
8,814
-445
-5% -$49.8K ﹤0.01% 3125
2020
Q1
$717K Sell
9,259
-4,595
-33% -$356K ﹤0.01% 3191
2019
Q4
$1.32M Sell
13,854
-1,926
-12% -$183K ﹤0.01% 3088
2019
Q3
$1.2M Sell
15,780
-1,554
-9% -$118K ﹤0.01% 3062
2019
Q2
$1.52M Sell
17,334
-650
-4% -$57K ﹤0.01% 2964
2019
Q1
$1.63M Sell
17,984
-525
-3% -$47.5K ﹤0.01% 2893
2018
Q4
$1.33M Sell
18,509
-3,345
-15% -$240K ﹤0.01% 2940
2018
Q3
$2.1M Buy
21,854
+1,435
+7% +$138K ﹤0.01% 2812
2018
Q2
$1.94M Sell
20,419
-4,483
-18% -$427K ﹤0.01% 2858
2018
Q1
$2.18M Buy
24,902
+3,688
+17% +$323K ﹤0.01% 2757
2017
Q4
$1.8M Buy
21,214
+2,282
+12% +$194K ﹤0.01% 2894
2017
Q3
$1.64M Sell
18,932
-342
-2% -$29.6K ﹤0.01% 2945
2017
Q2
$1.49M Buy
19,274
+197
+1% +$15.2K ﹤0.01% 3017
2017
Q1
$1.32M Sell
19,077
-2,659
-12% -$184K ﹤0.01% 3088
2016
Q4
$1.29M Buy
21,736
+4,009
+23% +$237K ﹤0.01% 3120
2016
Q3
$1.18M Buy
17,727
+2,521
+17% +$167K ﹤0.01% 3084
2016
Q2
$822K Buy
15,206
+1,078
+8% +$58.3K ﹤0.01% 3267
2016
Q1
$730K Sell
14,128
-1,438
-9% -$74.3K ﹤0.01% 3243
2015
Q4
$1.09M Buy
15,566
+2,201
+16% +$155K ﹤0.01% 3111
2015
Q3
$832K Buy
13,365
+417
+3% +$26K ﹤0.01% 3276
2015
Q2
$1.09M Sell
12,948
-855
-6% -$71.8K ﹤0.01% 3295
2015
Q1
$1.04M Sell
13,803
-522
-4% -$39.2K ﹤0.01% 3288
2014
Q4
$890K Buy
14,325
+867
+6% +$53.9K ﹤0.01% 3364
2014
Q3
$700K Buy
13,458
+3
+0% +$156 ﹤0.01% 3493
2014
Q2
$691K Sell
13,455
-6
-0% -$308 ﹤0.01% 3507
2014
Q1
$639K Buy
13,461
+2,526
+23% +$120K ﹤0.01% 3485
2013
Q4
$475K Buy
10,935
+735
+7% +$31.9K ﹤0.01% 3578
2013
Q3
$439K Sell
10,200
-2,142
-17% -$92.2K ﹤0.01% 3553
2013
Q2
$428K Buy
+12,342
New +$428K ﹤0.01% 3546